Anti-PINK1 antibody [N4/15]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(37 Publications)
Anti-PINK1 antibody [N4/15] (ab186303) is a mouse monoclonal antibody detecting PINK1 in Western Blot. Suitable for Human.
- Over 20 publications
View Alternative Names
BRPK, PTEN-induced putative kinase protein 1, PINK1
- WB
Lab
Western blot - Anti-PINK1 antibody [N4/15] (AB186303)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
ab181602 was used as a loading control at a 1/200000 dilution.
The expression of PINK1 is upregulated in response to valinomycin treatment (PMID : 22724072).
Left panel is incubated with ab186303 followed by secondary antibody Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/2000 dilution and right panel is incubated with ab323807 followed by Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/20000 dilution.
The blot of left panel was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
The blot of right panel was developed using a ECL substrate, allowing for the detection of proteins in the picogram to high-femtogram range.
All lanes:
Western blot - Anti-PINK1 antibody [N4/15] (ab186303) at 1/1000 dilution
Lane 1:
Untreated SK-OV-3 (human ovarian cancer epithelial cell) whole cell lysate at 20 µg
Lane 2:
SK-OV-3 treated with 30μM CCCP for 6h, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/2000 dilution
Predicted band size: 62 kDa
true
Reactivity data
Product details
What is this antibody validated in?
Anti-PINK1 antibody [N4/15] (ab186303) is a mouse monoclonal antibody and is validated for use in Western Blot (WB) in Human samples.
What is the molecular weight of PINK1?
Anti-PINK1 [N4/15] (ab186303) specifically detects a band for PINK1 (UniProt: Q9BXM7) at a molecular weight of 63kDa.
Trusted by the scientific community
Anti-PINK1 [N4/15] (ab186303) was first used in a scientific publication in 2014 and has been cited over 20 times in peer-reviewed journals.
The production method has been switched from hybridoma to recombinant on 24th Oct 2025.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PINK1 protein detects mitochondrial damage and recruits Parkin an E3 ubiquitin ligase to the damaged mitochondria. This interaction leads to the ubiquitylation of mitochondrial substrates and triggers their degradation. PINK1 Parkin and other proteins form a complex that facilitates the removal of damaged mitochondria through autophagy. This mechanism ensures cellular health and energy balance by maintaining a pool of functional mitochondria.
Pathways
PINK1 integrates into the mitochondrial quality control and mitophagy pathways. It has a fundamental role in the PINK1-Parkin pathway which is critical for maintaining mitochondrial integrity. In this pathway PINK1 phosphorylates both ubiquitin and Parkin enhancing Parkin's E3 ligase activity. Another pathway that PINK1 participates in is the PTEN-induced kinase pathway where it regulates mitochondrial dynamics and homeostasis via cross-talk with other mitochondrial proteins such as DJ-1 and LRRK2.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (37)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:15078 PubMed40301645
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neurology 16:1533092 PubMed40260133
2025
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology 40:2047-2058 PubMed40235277
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:11698 PubMed40188200
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medicine 20:16 PubMed39894836
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of assisted reproduction and genetics 42:923-936 PubMed39810070
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1491315 PubMed39726785
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 12:1464773 PubMed39512900
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational andrology and urology 13:2209-2228 PubMed39507862
2024
Applications
Unspecified application
Species
Unspecified reactive species
Brain pathology (Zurich, Switzerland) 35:e13316 PubMed39462160
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com